Bala-Miller, P., Macmullan, J., & Upchurch, L. (2007). Drugs, doctors and dinners. How companies influence health in the developing world. London: Consumers International.
Brax, H., Fadlallah, R., Al-Khaled, L., Nas, H., El Jardali, F., & Akl, E. (2017). Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS ONE, 12(4). Retrieved from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0175493.
Feldman, Y., Gauthier, R., & Schuler, T. (2013). Curbing misconduct in the pharmaceutical industry: Insights from behavioral ethics and the behavioral approach to law. Journal of Law, Medicine and Ethics, 41, 620–628.
Gagnon, M., & Lexchin, J. (2008). The cost of pushing pills. A new estimate of pharmaceutical promotion. PLoS Med. Retrieved from https://www.medscape.com/viewarticle/571493_print.
Gagnon, M.-A. (2013). Corruption of pharmaceutical markets: Addressing the misalignment of financial incentives and public health. Journal of Law, Medicine and Ethics, 41, 571–580.
Gagnon, M.-A., & Volesky, K. (2017). Merger mania: Mergers and acquisitions in the generic drug sector from 1995 to 2016. Globalization and Health, 13, 62.
Gaudillière, J.-P., & Thoms, U. (2015). The development of scientific marketing in the twentieth century. New York: Routledge.
Grochowski-Jones, R., & Ornstein, C. (2016). Matching industry payments to medicare prescribing patterns: An analysis for propublica. Retrieved from https://static.propublica.org/projects/d4d/20160317-matching-industry-payments.pdf?22.
Groves, K., Sketris, I., & Tett, S. (2003). Prescription drug samples—Does this marketing strategy counteract policies for quality use of medicines? Journal of Clinical Pharmacy and Therapeutics, 28, 259–271.
Habibi, R., Guénette, L., Lexchin, J., Reynolds, E., Wiktorowicz, M., & Mintzes, B. (2016). Regulating information of allowing deception? Pharmaceutical sales visits in Canada, Frances and the United States. Journal of Law, Medicine and Ethics, 44, 602–615.
Hunt, P. (2008, August 11). Interim report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. Geneva: United Nations General Assembly.
Lakoff, A. (2006). High contact: gifts and surveillance in Argentina. In Global Pharmaceuticals. Ethics, Markets and Practices. Petryna, A., Lakoff, A., & Kleinman, A. (Eds). Duke University Press, 111–135.
Larkin et al. (2017). Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA, 317(17), 1785–1795. https://jamanetwork.com/journals/jama/fullarticle/2623607.
Liu, Q. (2007, October). The dynamics of competitive drug detailing. The Johnson School at Cornell University. Ithaca, USA. Retrieved 2017, from https://pdfs.semanticscholar.org/6055/3b04014857d9d7fdd5bdfa538bd9e5c2dc74.pdf.
Mintzes, B., Lexchin, J., Sutherlang, J., Beaulie, M. D., & Wilkes, M. (2013). Pharmaceutical sales representatives and patient safety: A comparative prospective study of information quality in Canada, Frances and the United States. Journal of General Internal Medicine, 28, 1368–1375.
Mitchell, A., Winn, A., & Dusetzina, S. (2018). Pharmaceutical industry payments and oncologists. JAMA Internal Medicine, 178, 854.
Norris, P., Herxheimer, A., Lexchin, J., & Mansfield, P. (2005). Drug promotion: What we know, what we have yet to learn. Reviews of materials in the WHO/HAI database on drug promotion. London: World Health Organization and Health Action International.
Page, L. (2017, November 21). Sunshine act: Are doctors still enjoying free lunches from drug reps? Retrieved from Medscape. https://www.medscape.com/viewarticle/885792_2.
Parker, R. S., & Pettijohn, C. E. (2006). Pharmaceutical drug marketing strategies and tactics. Health Marketing Quarterly, 22, 27–43.
Petryna, A., Lakoff, A., & Kleinman, A. (2006). Global pharmaceuticals. Ethics, markets, practices. Durham: Duke University Press.
Ratanawijistrasin, S., & Wondemagegnehu, E. (2002). Effective drug regulation. A multicountry study. Geneva: WHO.
Sismondo, S. (2006). Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science, 39, 171–198.
Transparency International. Pharmaceuticals and Healthcare Programme. (2016). Corruption in the pharmaceutical sector. Diagnosing the challenges. London: Transparency International UK.